BioSpain 2010 Will Host 2,000 Business Meetings in Which More Than 600 Companies Will Come Together

MADRID, September 23, 2010 - BioSpain 2010 will host 2,000 business meetings, 135% more
than the previous event, between more than 600 companies, 25% of which are
not Spanish. This percentage includes 150 foreign companies and institutions,
which have decided to come to Spain to find new business opportunities within
the biotechnology sector. This figure has increased by 60% as compared to the
number of foreign companies that attended BioSpain 2008.

These figures turn BioSpain into the most important
biotechnology-related event held by a Southern European country and it has
also become a pioneer in Spain regarding the introduction of the partnering
system whereby bilateral meetings between companies are fostered.

Pamplona will be the host city for this fifth BioSpain event
(www.biospain2010.org) to be held from September 29th to October 1st.
This biannual event is organised by the Spanish Association of Biocompanies
(ASEBIO) and on this occasion it also has the collaboration of the Navarre
Government, through the Navarre Development Association (SODENA) with a view
to disseminating biotechnological knowledge in Spain and contributing to its
development. In turn, the event will be officially sponsored by companies as
prestigious as Merck, Zeltia, AB BIOTICS, Genetrix, Genoma Espana, Caja
Navarra and ICEX. The event is expected to be attended by more than 1,200
participants.

BioSpain 2010 will have 132 stands in the commercial
exhibition, 15% more than on the previous event. These stands will provide
room for 160 companies, 24% of which are not Spanish (38), which once again
underlines the international spirit of this event as one of its highlights.

Furthermore, BioSpain 2010 will be honoured with the presence
of three internationally acknowledged lecturers, such as Carlos Cordon-Cardo,
Deputy Director of the Department of Pathology of Columbia University; Larry
Fritz, CEO of Covella Pharmaceuticals and partner of the venture capital firm
Westfield Capital Management, and Conny Bogentoft, CEO of Karolinska
Development AB. Cordon-Cardo will explain the role of tumour stem cells;
Larry Fritz will lecture on how to create and develop a successful
biotechnology company and Bogentoft will explain how to materialise
technological transfer, in other words, how to turn an idea into a business
activity.

    For additional information:

    Lucia Cecilia Mercado
    ASEBIO Communication Manager
    Phone No.: +34-91-210-93-74
    Mobile: +34-663-117-293
    lcecilia@asebio.com 

    Berbes Asociados
    Maribel Otero/Jorge Sanchez
    Phone No.: +34-91-563-23-00
    maribelotero@berbes.com
    jorgesanchez@berbes.com

For additional information: Lucia Cecilia Mercado, ASEBIO Communication Manager, Phone No.: +34-91-210-93-74, Mobile: +34-663-117-293, lcecilia at asebio.com; Berbes Asociados, Maribel Otero/Jorge Sanchez, Phone No.: +34-91-563-23-00, maribelotero at berbes.com, jorgesanchez at berbes.com